Andrew C. White

This study identifies macrophage-driven NK cell infiltration during tumor regression and subsequent exclusion during residual disease as key factors in therapy resistance, highlighting macrophage-NK cell crosstalk as a therapeutic target.

This study uses single-cell RNA sequencing to reveal molecular heterogeneity in quiescent melanocyte stem cells and identifies novel subpopulations with distinct immune privilege and differentiation potential.